» Articles » PMID: 28798404

An in Vivo High-throughput Screening for Riboswitch Ligands Using a Reverse Reporter Gene System

Overview
Journal Sci Rep
Specialty Science
Date 2017 Aug 12
PMID 28798404
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Riboswitches are bacterial RNA elements that regulate gene expression in response to metabolite or ion abundance and are considered as potential drug targets. In recent years a number of methods to find non-natural riboswitch ligands have been described. Here we report a high-throughput in vivo screening system that allows identifying OFF-riboswitch modulators in a 384 well bioluminescence assay format. We use a reverse reporter gene setup in Bacillus subtilis, consisting of a primary screening assay, a secondary assay as well as counter assays to detect compounds in a library of 1,280 molecules that act on the guanine-responsive xpt riboswitch from B. anthracis. With this in vivo high-throughput approach we identified several hit compounds and could validate the impact of one of them on riboswitch-mediated gene regulation, albeit this might not be due to direct binding to the riboswitch. However, our data demonstrate the capability of our screening assay for bigger high-throughput screening campaigns. Furthermore, the screening system described here can not only be generally employed to detect non-natural ligands or compounds influencing riboswitches acting as genetic OFF switches, but it can also be used to investigate natural ligands of orphan OFF-riboswitches.

Citing Articles

Recent advances in high-throughput screening methods for small molecule modulators in bacteria.

Addis H, Carlson E Curr Opin Chem Biol. 2025; 85:102571.

PMID: 39954453 PMC: 11893234. DOI: 10.1016/j.cbpa.2025.102571.


A sensitive and scalable fluorescence anisotropy single stranded RNA targeting approach for monitoring riboswitch conformational states.

Rivera M, Ayon O, Diaconescu-Grabari S, Pottel J, Moitessier N, Mittermaier A Nucleic Acids Res. 2024; 52(6):3164-3179.

PMID: 38375901 PMC: 11014391. DOI: 10.1093/nar/gkae118.


Fluorescent Ligand Equilibrium Displacement: A High-Throughput Method for Identification of FMN Riboswitch-Binding Small Molecules.

Tidwell E, Kilde I, Leskaj S, Koutmos M Int J Mol Sci. 2024; 25(2).

PMID: 38255809 PMC: 11154562. DOI: 10.3390/ijms25020735.


Identification of Efflux Substrates Using a Riboswitch-Based Reporter in Pseudomonas aeruginosa.

Urdaneta-Paez V, Hamchand R, Anthony K, Crawford J, Sutherland A, Kazmierczak B mSphere. 2023; 8(2):e0006923.

PMID: 36946743 PMC: 10117056. DOI: 10.1128/msphere.00069-23.


Overview on Strategies and Assays for Antibiotic Discovery.

Rutten A, Kirchner T, Musiol-Kroll E Pharmaceuticals (Basel). 2022; 15(10).

PMID: 36297414 PMC: 9607151. DOI: 10.3390/ph15101302.


References
1.
Lunse C, Mayer G . Reporter Gene-Based Screening for TPP Riboswitch Activators. Methods Mol Biol. 2016; 1520:227-235. DOI: 10.1007/978-1-4939-6634-9_13. View

2.
Hughes J, Rees S, Kalindjian S, Philpott K . Principles of early drug discovery. Br J Pharmacol. 2010; 162(6):1239-49. PMC: 3058157. DOI: 10.1111/j.1476-5381.2010.01127.x. View

3.
Nelson J, Plummer M, Blount K, Ames T, Breaker R . Small molecule fluoride toxicity agonists. Chem Biol. 2015; 22(4):527-534. PMC: 4617673. DOI: 10.1016/j.chembiol.2015.03.016. View

4.
Deigan K, Ferre-DAmare A . Riboswitches: discovery of drugs that target bacterial gene-regulatory RNAs. Acc Chem Res. 2011; 44(12):1329-38. PMC: 3193592. DOI: 10.1021/ar200039b. View

5.
Blount K, Breaker R . Riboswitches as antibacterial drug targets. Nat Biotechnol. 2006; 24(12):1558-64. DOI: 10.1038/nbt1268. View